375 related articles for article (PubMed ID: 22419126)
1. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia.
Guay SP; Brisson D; Munger J; Lamarche B; Gaudet D; Bouchard L
Epigenetics; 2012 May; 7(5):464-72. PubMed ID: 22419126
[TBL] [Abstract][Full Text] [Related]
2. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.
Guay SP; Brisson D; Lamarche B; Gaudet D; Bouchard L
Epigenetics; 2014 May; 9(5):718-29. PubMed ID: 24504152
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability.
Guay SP; Brisson D; Lamarche B; Marceau P; Vohl MC; Gaudet D; Bouchard L
Atherosclerosis; 2013 Jun; 228(2):413-20. PubMed ID: 23623643
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease.
Guay SP; Légaré C; Brisson D; Mathieu P; Bossé Y; Gaudet D; Bouchard L
Epigenomics; 2016 Mar; 8(3):359-71. PubMed ID: 26950807
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration.
Guay SP; Voisin G; Brisson D; Munger J; Lamarche B; Gaudet D; Bouchard L
Epigenomics; 2012 Dec; 4(6):623-39. PubMed ID: 23244308
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients.
Kyriakou T; Pontefract DE; Viturro E; Hodgkinson CP; Laxton RC; Bogari N; Cooper G; Davies M; Giblett J; Day IN; Simpson IA; Albrecht C; Ye S
Hum Mol Genet; 2007 Jun; 16(12):1412-22. PubMed ID: 17412755
[TBL] [Abstract][Full Text] [Related]
7. ABCA1 and ABCG1 DNA methylation in epicardial adipose tissue of patients with coronary artery disease.
Miroshnikova VV; Panteleeva AA; Pobozheva IA; Razgildina ND; Polyakova EA; Markov AV; Belyaeva OD; Berkovich OA; Baranova EI; Nazarenko MS; Puzyrev VP; Pchelina SN
BMC Cardiovasc Disord; 2021 Nov; 21(1):566. PubMed ID: 34837967
[TBL] [Abstract][Full Text] [Related]
8. Effect of ABCA1 promoter methylation on premature coronary artery disease and its relationship with inflammation.
An F; Liu C; Wang X; Li T; Fu H; Bao B; Cong H; Zhao J
BMC Cardiovasc Disord; 2021 Feb; 21(1):78. PubMed ID: 33557767
[TBL] [Abstract][Full Text] [Related]
9. [Significance of -191G/C single nucleotide polymorphisms in the promoter region of ATP-binding cassette transporter gene in coronary artery disease].
Liu L; Guo ZG; Wang QG; Liu SL; Lai WY; Tu Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):660-2, 666. PubMed ID: 15958302
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
[TBL] [Abstract][Full Text] [Related]
11. A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients.
Versmissen J; Oosterveer DM; Yazdanpanah M; Mulder M; Dehghan A; Defesche JC; Kastelein JJ; Sijbrands EJ
Eur Heart J; 2011 Feb; 32(4):469-75. PubMed ID: 20595220
[TBL] [Abstract][Full Text] [Related]
12. Common variants in the ATP-binding cassette transporter 1 gene with decreased HDL-cholesterol levels and coronary artery disease.
Catakoglu AB; Duman BS; Kurtoğlu H; Ersöz M; Sener M; Celebi H; Cağatay P; Aytekin V; Aytekin S
Arch Med Res; 2008 Nov; 39(8):735-42. PubMed ID: 18996286
[TBL] [Abstract][Full Text] [Related]
13. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
[TBL] [Abstract][Full Text] [Related]
14. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
[TBL] [Abstract][Full Text] [Related]
15. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.
Kakko S; Kelloniemi J; von Rohr P; Hoeschele I; Tamminen M; Brousseau ME; Kesäniemi YA; Savolainen MJ
Atherosclerosis; 2003 Feb; 166(2):285-90. PubMed ID: 12535741
[TBL] [Abstract][Full Text] [Related]
16. Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.
Orsoni A; Villard EF; Bruckert E; Robillard P; Carrie A; Bonnefont-Rousselot D; Chapman MJ; Dallinga-Thie GM; Le Goff W; Guerin M
J Lipid Res; 2012 Apr; 53(4):767-75. PubMed ID: 22338009
[TBL] [Abstract][Full Text] [Related]
17. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.
Clee SM; Zwinderman AH; Engert JC; Zwarts KY; Molhuizen HO; Roomp K; Jukema JW; van Wijland M; van Dam M; Hudson TJ; Brooks-Wilson A; Genest J; Kastelein JJ; Hayden MR
Circulation; 2001 Mar; 103(9):1198-205. PubMed ID: 11238261
[TBL] [Abstract][Full Text] [Related]
18. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
[TBL] [Abstract][Full Text] [Related]
19. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
[TBL] [Abstract][Full Text] [Related]
20. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
Lutucuta S; Ballantyne CM; Elghannam H; Gotto AM; Marian AJ
Circ Res; 2001 May; 88(9):969-73. PubMed ID: 11349008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
